David Zhang was appointed to serve as an independent director of the company on August 1, 2026.
4 reports, 1 independent
Updated 00:00
Still developing
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
David Zhang was appointed to serve as an independent director of the company on August 1, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Zhang joins Aardvark's board and supports BMS regulatory filings for MyoKardia.1 source
David Zhang appointed as independent director of the company.1 source
Keep exploring
The entities involved
-
company
legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective
-
David Zhang
researcher (ORCID 0000-0002-3358-4458)
Nothing else this week.